Plaque-form urticaria pigmentosa Advocacy Hub | UniteRare

At a Glance

Live from database

💊

1FDA treatments

Regulatory Watchboard

No FDA or trial events recorded yet for Plaque-form urticaria pigmentosa.

Financial Assistance

FINANCIAL LANDSCAPE SUMMARY

Total programs

No financial assistance programs currently listed for Plaque-form urticaria pigmentosa.
Check the disease page for updates →

Approved Treatments

1 FDA-approved

MALARONE

(ATOVAQUONE AND PROGUANIL HYDROCHLORIDE)standard

GlaxoSmithKline LLC

Antimalarial [EPC]

12.1 Mechanism of Action MALARONE, a fixed-dose combination of atovaquone and proguanil hydrochloride, is an antimalarial agent [see Microbiology ( 12...

FDA label ↗

View full treatment details on disease page →

Clinical Trial Landscape

No active clinical trials currently recruiting for Plaque-form urticaria pigmentosa.
Search all trials →

Search clinical trials for Plaque-form urticaria pigmentosa →

Recent News & Research

No recent news articles indexed yet for Plaque-form urticaria pigmentosa.
Search PubMed for Plaque-form urticaria pigmentosa →

Browse all Plaque-form urticaria pigmentosa news →

Specialist Network

No specialists currently listed for Plaque-form urticaria pigmentosa.

View all Plaque-form urticaria pigmentosa specialists →

Quick Actions

📄

View Disease Page

Full profile, treatments, community

🔬

Search Clinical Trials

Find recruiting studies now

🩺

Find Specialists

Ranked by expertise & trials

💰

Financial Assistance

Copay cards, PAPs, grants

📰